See All Slides - tctmd.com

Slides

Presentation TCT 2012

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

Presenter: Markus Schlaich

October 23, 2012

Presentation TCT 2012

Contracts 101

Presenter: Thomas Tu

October 23, 2012

Presentation TCT 2012

TCT-70. Comparison of Efficacy and Safety Between Sirolimus, Paclitaxel, Everolimus-eluting Stent and SeQuent™ Please, a Drug-eluting Balloon on the Outcome of Patients with...

Presenter: Sunao Nakamura

October 23, 2012

Presentation TCT 2012

Two MitraClip Case Surprises: One in Whom It Worked and One in Whom It Didn't

Presenter: Stephan Baldus

October 23, 2012

Presentation TCT 2012

Modeling the Risk of Stroke and Bleeding in Atrial Fibrillation: What Are the Optimal Risk Scores?

Presenter: Roxana Mehran

October 23, 2012

Presentation TCT 2012

Hybrid Revascularization: The Vanderbilt Approach

Presenter: David Zhao

October 23, 2012

Presentation TCT 2012

Design of a Fully Drug-Eluting Bioabsorbable Scaffold with EPC-Capture Technology

Presenter: Robert Cottone

October 23, 2012

Presentation TCT 2012

Respicardia

Presenter: Robin Germany

October 23, 2012

Presentation TCT 2012

Orsiro (BIOTRONIK) Program Update

Presenter: Stephan Windecker

October 23, 2012

Presentation TCT 2012

Introductory Lecture. A New Paradigm Revisited: From Ischemia to Vulnerable Plaque

Presenter: Gregg Stone

October 23, 2012

Advertisement

Slides

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

Contracts 101

TCT-70. Comparison of Efficacy and Safety Between Sirolimus, Paclitaxel, Everolimus-eluting Stent and SeQuent™ Please, a Drug-eluting Balloon on the Outcome of Patients with...

Two MitraClip Case Surprises: One in Whom It Worked and One in Whom It Didn't

Modeling the Risk of Stroke and Bleeding in Atrial Fibrillation: What Are the Optimal Risk Scores?

Hybrid Revascularization: The Vanderbilt Approach

Design of a Fully Drug-Eluting Bioabsorbable Scaffold with EPC-Capture Technology

Respicardia

Orsiro (BIOTRONIK) Program Update

Introductory Lecture. A New Paradigm Revisited: From Ischemia to Vulnerable Plaque

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content